Back to Search
JOHN ROTROSEN, MD
MD
Psychiatry Physician
NPI: 1801982533Individual
Specialties, Licenses & Credentials
Psychiatry PhysicianPrimary
Psychiatry & Neurology — Psychiatry
Code: 2084P0800X
127684(NY)
Clinical Trials (4)
4
Linked Trials
0
Recruiting
1
With Results
Methylphenidate Raclopride Positron Emission Tomography (PET) Test - 11
NCT00015301COMPLETEDPHASE4PRINCIPAL_INVESTIGATOR
Modeling Impaired Judgement in Cocaine Abusers - 6
NCT00015236COMPLETEDPHASE4PRINCIPAL_INVESTIGATOR
Pathophysiological Subtyping of Abnormalities in Cocaine Dependence - 9
NCT00015275COMPLETEDPHASE4PRINCIPAL_INVESTIGATOR
Extended-Release Naltrexone vs. Buprenorphine for Opioid Treatment
NCT02032433COMPLETEDPHASE4PRINCIPAL_INVESTIGATOR
Research & Publications (20)
Sustained-release naltrexone for opioid dependence.
PMID 40342086·Cochrane Database Syst Rev·2025
1-meta
Empirically contrasting urine drug screening-based opioid use disorder treatment outcome definitions.
PMID 38616571·Addiction·2024
8-other
Associations between stimulant use and return to illicit opioid use following initiation onto medication for opioid use disorder.
PMID 37712113·Addiction·2024
8-other
Twelve-Month Outcomes for Remitters Following Electroconvulsive Therapy for Depression.
PMID 35452195·J Clin Psychiatry·2022
8-other
Opioid agonist treatment for people who are dependent on pharmaceutical opioids.
PMID 36063082·Cochrane Database Syst Rev·2022
1-meta
Co-occurring Depression and Suicidal Ideation in Opioid Use Disorder: Prevalence and Response During Treatment With Buprenorphine-Naloxone and Injection Naltrexone.
PMID 35452194·J Clin Psychiatry·2022
2-rct
Association between dynamic dose increases of buprenorphine for treatment of opioid use disorder and risk of relapse.
PMID 34338389·Addiction·2022
2-rct
Methamphetamine/amphetamine use over time among persons with opioid use disorders treated with buprenorphine/naloxone versus extended-release naltrexone.
PMID 35605529·Drug Alcohol Depend·2022
2-rct
Sublingual Buprenorphine-Naloxone Compared With Injection Naltrexone for Opioid Use Disorder: Potential Utility of Patient Characteristics in Guiding Choice of Treatment.
PMID 34170188·Am J Psychiatry·2021
4-observational
Association between methadone or buprenorphine use during medically supervised opioid withdrawal and extended-release injectable naltrexone induction failure.
PMID 33771287·J Subst Abuse Treat·2021
8-other
Examination of Correlates of OUD Outcomes in Young Adults: Secondary Analysis From the XBOT Trial.
PMID 34075644·Am J Addict·2021
2-rct
Comparative effectiveness of extended-release naltrexone versus buprenorphine-naloxone for opioid relapse prevention (X:BOT): a multicentre, open-label, randomised controlled trial.
PMID 29150198·Lancet·2018
4-observational
NIDA Clinical Trials Network CTN-0051, Extended-Release Naltrexone vs. Buprenorphine for Opioid Treatment (X:BOT): Study design and rationale.
PMID 27521809·Contemp Clin Trials·2016
4-observational
Misuse and diversion of stimulants prescribed for ADHD: a systematic review of the literature.
PMID 18174822·J Am Acad Child Adolesc Psychiatry·2008
1-meta
Substance abuse treatment clinician opinions and infectious disease service delivery.
PMID 19197590·J Addict Dis·2009
4-observational
Heroin addiction in African Americans: a hypothesis-driven association study.
PMID 19500151·Genes Brain Behav·2009
8-other
Network homogeneity reveals decreased integrity of default-mode network in ADHD.
PMID 18190970·J Neurosci Methods·2008
8-other
States and substance abuse treatment programs: funding and guidelines for infection-related services.
PMID 18381995·Am J Public Health·2008
8-other
Genetic susceptibility to heroin addiction: a candidate gene association study.
PMID 18518925·Genes Brain Behav·2008
8-other
Prenatal protein deprivation alters dopamine-mediated behaviors and dopaminergic and glutamatergic receptor binding.
PMID 18703024·Brain Res·2008
7-preclinical
Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.
Contact & Hours
- Address
- 423 EAST 23 ST, PSYCHIATRY VA NYHHS
NEW YORK, NY 10010 - Phone
- (212) 951-3294
Quick Facts
- NPI
- 1801982533
- Entity Type
- Individual
- Gender
- Male
- Medicare
- Not confirmed
- Specialties
- 1
- Locations
- 1
- Clinical Trials
- 4
- Publications
- 20
Are you this provider?
Claim Your Profile